Benefits Treatment Length & Supply Tier, Extended, and Monthly plan breakdowns Tier Plans Most Popular Supply ~810 weeks of medication Details Our most popular option, providing approximately 810 weeks of medication with excellent flexibility for dose titration as needed
The skin around eyes is thinner and more sensitive
Related Topics: Shoulder Impingement Shoulder Labral Tear Frozen Shoulder Shoulder Instability Arthritis of the Shoulder Shoulder Fracture Acromioclavicular (AC) Arthritis Rotator Cuff Tear Shoulder Pain SLAP Tears Clavicle Fracture Fracture of the Shoulder Blade (Scapula) Shoulder Trauma Shoulder Dislocation Anterior Shoulder Instability Posterior Shoulder Instability Sternoclavicular Joint (SC joint) Overhead Athlete's Shoulder Subacromial Impingement Syndrome Glenoid Fractures Shoulder Disorders Snapping Scapula Proximal Humerus Fractures Baseball and Shoulder Injuries Acromioclavicular (AC) Joint Osteoarthritis Proximal Biceps Tendinitis Rotator Cuff Pain Internal Impingement of the Shoulder Rotator Cuff Re-tear AC Joint Separation Shoulder Tendonitis Little League Shoulder Throwing Injuries of the Shoulder Subluxation Rotator Cuff Calcification Partial Rotator Cuff Tear Bicep Tendon Rupture Proximal Biceps Tendon Rupture Calcification Tendinitis AC Joint Dislocation/Acromioclavicular Joint Dislocation Long Head Biceps Tendon Rupture Shoulder Labral Tear with Instability Multidirectional Instability of the Shoulder Periprosthetic Shoulder Fracture
May support improved recovery and adaptation by reducing cellular burden from accumulated senescent cells
Injection-Site Reactions Soreness or tenderness at the injection site, typically lasting a few hours to a day Minor redness or swelling that usually resolves within 24 hours Slight bruising , more common if the client is taking blood thinners or supplements like fish oil Mild itching around the injection area, which is generally transient These are common responses to any subcutaneous injection, not reactions specific to lipotropic formulas
Cells, 13 (7), Article 581
